Literature DB >> 22271125

Overuse of health care services in the United States: an understudied problem.

Deborah Korenstein1, Raphael Falk, Elizabeth A Howell, Tara Bishop, Salomeh Keyhani.   

Abstract

BACKGROUND: Overuse, the provision of health care services for which harms outweigh benefits, represents poor quality and contributes to high costs. A better understanding of overuse in US health care could inform efforts to reduce inappropriate care. We performed an extensive search for studies of overuse of therapeutic procedures, diagnostic tests, and medications in the United States and describe the state of the literature.
METHODS: We searched MEDLINE (1978-2009) for studies measuring US rates of overuse of procedures, tests, and medications, augmented by author tracking, reference tracking, and expert consultation. Four reviewers screened titles; 2 reviewers screened abstracts and full articles and extracted data including overuse rate, type of service, clinical area, and publication year.
RESULTS: We identified 172 articles measuring overuse: 53 concerned therapeutic procedures; 38, diagnostic tests; and 81, medications. Eighteen unique therapeutic procedures and 24 diagnostic services were evaluated, including 10 preventive diagnostic services. The most commonly studied services were antibiotics for upper respiratory tract infections (59 studies), coronary angiography (17 studies), carotid endarterectomy (13 studies), and coronary artery bypass grafting (10 studies). Overuse of carotid endarterectomy and antibiotics for upper respiratory tract infections declined over time.
CONCLUSIONS: The robust evidence about overuse in the United States is limited to a few services. Reducing inappropriate care in the US health care system likely requires a more substantial investment in overuse research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271125     DOI: 10.1001/archinternmed.2011.772

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  91 in total

Review 1.  From HMOs to ACOs: the quest for the Holy Grail in U.S. health policy.

Authors:  Theodore Marmor; Jonathan Oberlander
Journal:  J Gen Intern Med       Date:  2012-03-13       Impact factor: 5.128

2.  Engaging physicians and patients in conversations about unnecessary tests and procedures: Choosing Wisely Canada.

Authors:  Wendy Levinson; Tai Huynh
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

Review 3.  Race/Ethnicity and overuse of care: a systematic review.

Authors:  Nancy R Kressin; Peter W Groeneveld
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

4.  [Rationalization and rationing at the bedside. A normative and empirical status quo analysis].

Authors:  D Strech
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-01-04       Impact factor: 0.840

5.  [Avoidance of overuse as an integral part of medical professionalism. Conceptual analysis and new perspective].

Authors:  D Strech
Journal:  Z Gerontol Geriatr       Date:  2014-01       Impact factor: 1.281

6.  Ensuring appropriate use of cardiac imaging.

Authors:  Thomas P Power
Journal:  J Digit Imaging       Date:  2013-10       Impact factor: 4.056

7.  The Lake Wobegon effect: are all cancer patients above average?

Authors:  Jacqueline H Wolf; Kevin S Wolf
Journal:  Milbank Q       Date:  2013-12       Impact factor: 4.911

8.  Test ordering for preventive health care among family medicine residents.

Authors:  Daisy Fung; Inge Schabort; Catherine A MacLean; Farhan M Asrar; Ayesha Khory; Ben Vandermeer; G Michael Allan
Journal:  Can Fam Physician       Date:  2015-03       Impact factor: 3.275

9.  How can bedside rationing be justified despite coexisting inefficiency? The need for 'benchmarks of efficiency'.

Authors:  Daniel Strech; Marion Danis
Journal:  J Med Ethics       Date:  2012-12-20       Impact factor: 2.903

10.  Physician decision making for colorectal cancer screening in the elderly.

Authors:  Carmen L Lewis; Denise Esserman; Christopher DeLeon; Michael P Pignone; Donald E Pathman; Carol Golin
Journal:  J Gen Intern Med       Date:  2013-03-29       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.